2nd Annual

PHARMAOMICS & AI 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Brett Hill

Brett Hill

Arcturus Therapeutics

Close icon
Ricardo Bastos

Ricardo Bastos

ONI

Brett Hill

Brett Hill

Arcturus Therapeutics

Craig Martin

Craig Martin

University of Massachusetts Amherst

THE PREMIER FORUM FOR AI AND OMICS-DRIVEN APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY

Welcome to PHARMA OMICS & AI 2026, an event that brings together industry leaders to explore how AI, ML, and multi-omics are transforming drug discovery, development, and real-world evidence.

The industry faces challenges such as biased and siloed data, limited scalability in multi-omics integration, and regulatory uncertainty. However, clearer methodologies and stronger data standards can drive faster therapy development, expand precision medicine, and reduce R&D costs.

Join us to gain practical insights, exchange ideas with peers, and help advance safe, effective, data-driven innovations across the pharmaceutical landscape.

key topics for

Emerging AI-driven solutions to overcome bioprocessing challenges

Learn how AI deployment in bioprocessing with PAT and digital twins reduces errors, supports predictive maintenance, and accelerates compliant batch release.

Advances in bioinformatics and omics for precision medicine and biomarkers

See how single-cell and spatial bioinformatics uncover disease pathways, reveal biomarkers, enable smarter trials, and inform treatment decisions.

Case studies highlighting data platforms for discovery and development

Explore innovative data platforms that break silos, streamline access, and add built-in checks to accelerate reliable AI and smarter decision-making in pharma.

Applying AI and ML to accelerate drug discovery, design, and development

Discover AI and ML across end-to-end R&D, from identifying targets and designing molecules to choosing sites, forecasting enrollment, and optimizing protocols.

Strategies to integrate multi-omics and patient-level data at scale

Find solutions to multi-omics integration challenges and link genomics, proteomics, and metabolomics with clinical data to deliver precision therapies at scale.

Upcoming AI regulations and safety standards across the Pharma lifecycle

Navigate FDA and EMA expectations for AI across the pharma lifecycle while building compliant, GxP-ready systems and pipelines for reliable implementation.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • RESEARCH

    16 Nov 2025

    New AI Platforms Push Drug Discovery Into Higher Gear
  • INNOVATION

    11 Nov 2025

    AI Is Rewriting the Race for Multi Omics Discovery
  • INNOVATION

    24 Oct 2025

    Mystra Ignites New Hopes for Faster Drug Targets
  • TECHNOLOGY

    20 Oct 2025

    Can AI Reboot the Pace of Pharma Research?

Inside the AI Rush Reshaping US Biotech

Inside the AI Rush Reshaping US Biotech

INSIGHTS

15 Oct 2025

Nabla Bio and Takeda expand their second AI biologics deal as momentum grows and biotech firms rush to modernize discovery

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Hongfeng Deng

Sanofi

Brett Hill

Arcturus Therapeutics

Daniel Dixon

TriLink BioTechnologies

Show more Speakers

Past Attendees

Sanofi

Hongene Biotech

TriLink BioTechnologies

Arranta Bio Holdings LLC

Aldevron

Orna Therapeutics

CATUG Biotechnology

DNA Script

Helix Biotech

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
4BasebioBIA SeparationsEclipseCATUG
arrow icon

related events in the series